首页 > 市场调查报告书 > 食物/饮料

食品添加剂机能性食品

市场调查报告书

商品编码

1550774

人乳寡糖市场：按应用、按类型、按地区

Human Milk Oligosaccharides Market, By Application, By Type, By Geography

出版日期: 2024年07月30日 | 出版商:

Coherent Market Insights | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

简介目录

人乳寡糖(HMO) 市场预计 2024 年为 2.986 亿美元，预计到 2031 年将达到 7.705 亿美元，2024 年至 2031 年复合年增长率为 14.5%。

报告范围		报告详情
基准年	2023年	2024年市场规模	2.986 亿美元
实际资料	2019年至2023年	预测期	从2024年到2031年
预测 2024-2031 年复合年增长率：	14.50%	2031年价值预测	7.705 亿美元

图.2024年按地区分類的人乳寡糖市场份额（%）

人乳寡糖(HMO) 是母乳中发现的复合糖，可支持婴儿肠道有益细菌的生长，并提供对致病菌的保护。作为母乳中继乳糖和脂肪之后第三丰富的固态成分，HMO 模仿婴儿肠道黏膜内层的成分，可防止病原体在肠壁上附着和定殖。研究和开发表明，HMO 可促进婴儿大脑发育并刺激免疫细胞发育。 HMO 已被证明具有与母乳相似的益生元和营养特性，因此正在被纳入婴儿奶粉中，为奶瓶餵食的婴儿提供健康益处。

市场动态：

人们越来越认识到 HMO 在婴儿营养和市场开发中的重要性，推动了全球人乳寡糖市场的发展。由于许多母亲面临母乳哺育困难，对 HMO 强化婴儿奶粉的需求显着增加。主要市场参与者已开发出透过发酵各种乳製品和蔬菜原料生产 HMO 的技术能力。然而，生产过程的高成本对市场成长构成挑战。正在进行的专注于降低生产成本的研究可能会为 HMO 在婴儿营养之外的临床营养、个人护理以及补充食品和饮料等领域的更广泛应用带来机会。

本研究的主要特点

本报告详细分析了全球人乳寡糖市场，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
它还阐明了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
它包括基于公司亮点、产品系列、主要亮点、绩效和策略等参数的全球人乳寡糖市场主要企业的概况。
该报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球人乳寡糖市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
相关人员可以透过用于分析全球人乳寡糖市场的各种策略矩阵来促进他们的决策。

市场占有率分析
公司简介
- ZuChem Inc.
- Merck &Co. Inc.
- Chr. Hansen Holding AS
- Royal FrieslandCampina NV
- BASF
- IFF（DuPont Nutrition &Health）
- Gnubiotics
- Inbiose NV
- Carbosynth Holdings Limited
- Royal DSM NV
- Kyowa Hakko Europe GmbH
- Elicityl SA
- FrieslandCampina Ingredients
- Glycom A/S
- Dextra Laboratories Limited
- Rajvi Enterprise

第九章分析师建议

命运之轮
分析师观点
一致的机会图

第10章

参考
调查方法

简介目录

Product Code: CMI5064

The human milk oligosaccharides market is estimated to be valued at USD 298.6 Mn in 2024 and is expected to reach USD 770.5 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 298.6 Mn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	14.50%	2031 Value Projection:	US$ 770.5 Mn

Figure. Human Milk Oligosaccharides Market Share (%), By Region 2024

Human Milk Oligosaccharides Market - IMG1

Human milk oligosaccharides (HMOs) are complex sugars found in breastmilk that support the growth of beneficial gut bacteria in infants and provide protection against pathogenic bacteria. As the third most abundant solid component in breastmilk after lactose and fat, HMOs mimic components of the mucosal layer in the infant gut and prevent pathogens from attaching to and colonizing the intestinal wall. Research has shown that HMOs can promote brain development and stimulate immune cell development in infants. Due to their demonstrated prebiotic and nutritional properties similar to human breastmilk, HMOs are being incorporated into infant formula to deliver health benefits to bottle-fed babies.

Market Dynamics:

The global human milk oligosaccharides market is driven by growing awareness about the importance of HMOs in infant nutrition and development. As many mothers face difficulties in breastfeeding, the demand for HMO-fortified infant formula is increasing significantly. Major market players have developed technological capabilities to produce HMOs through the fermentation of various dairy and plant-based ingredients. However, the high costs involved in the production process pose a challenge to market growth. Ongoing research focused on reducing production costs could open up opportunities for the wider application of HMOs beyond infant nutrition in areas such as clinical nutrition, personal care, and supplemental food & beverages.

Key Features of the Study:

This report provides in-depth analysis of the global human milk oligosaccharides market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global human milk oligosaccharides market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include ZuChem Inc., Merck & Co. Inc., Chr. Hansen Holding AS , Royal FrieslandCampina NV, BASF, IFF (DuPont Nutrition & Health), Gnubiotics, Inbiose NV, Carbosynth Holdings Limited, Royal DSM N.V, Kyowa Hakko Europe GmbH, Elicityl SA, FrieslandCampina Ingredients, Glycom A/S, Dextra Laboratories Limited, and Rajvi Enterprise
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global human milk oligosaccharides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human milk oligosaccharides market

Detailed Segmentation-

By Application:
- Infant Formula
- Dietary Supplements
- Functional Food and Beverage
By Type:
- 2'FL
- 3'FL
- 3'SL
- 6'SL
- LNT
- LNnT
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- ZuChem Inc.
- Merck & Co. Inc.
- Chr. Hansen Holding AS
- Royal FrieslandCampina NV
- BASF
- IFF (DuPont Nutrition & Health)
- Gnubiotics
- Inbiose NV
- Carbosynth Holdings Limited
- Royal DSM N.V
- Kyowa Hakko Europe GmbH
- Elicityl SA
- FrieslandCampina Ingredients
- Glycom A/S
- Dextra Laboratories Limited
- Rajvi Enterprise

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Application
- Market Snippet, By Type
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trend
- Mergers and Acquisitions

4. Global Human Milk Oligosaccharides Market - Impact of Coronavirus (COVID-19) Pandemic

Overview
Factors Affecting the Global Human Milk Oligosaccharides Market
Impact Analysis

5. Global Human Milk Oligosaccharides Market, By Application, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Infant Formula
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends
Dietary Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends
Functional Food and Beverage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends

6. Global Human Milk Oligosaccharides Market, By Type, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
2'FL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends
3'FL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends
3'SL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends
6'SL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends
LNT
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends
LNnT
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
- Segment Trends

7. Global Human Milk Oligosaccharides Market, By Region, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
North America
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Mn))
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East & Africa
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East & Africa

8. Competitive Landscape

Market Share Analysis
Company Profiles
- ZuChem Inc.
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Merck & Co. Inc.
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Chr. Hansen Holding AS
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Royal FrieslandCampina NV
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- BASF
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- IFF (DuPont Nutrition & Health)
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Gnubiotics
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Inbiose NV
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Carbosynth Holdings Limited
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Royal DSM N.V
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Kyowa Hakko Europe GmbH
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Elicityl SA
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- FrieslandCampina Ingredients
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Glycom A/S
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Dextra Laboratories Limited
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Rajvi Enterprise
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates

9. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. Section

References
Research Methodology
About Us and Sales Contact
- Browse 25 market data tables* and 20 figures* on "Global Human Milk Oligosaccharides Market" - Global forecast to 2031.

02-2729-4219

+886-2-2729-4219

License/价格

人乳寡糖市场：按应用、按类型、按地区